Innovations in Immunology: Drug resistance is a constant threat to progress in HIV, TB and malaria vaccines

September 3, 2019

Despite global efforts at prevention and improving control, the public health impact of these diseases is still huge. Medicines are the mainstay of control efforts, but drug resistance is a constant threat. Effective vaccines are urgently required and would add substantially to the ongoing efforts to curb these diseases.

The first vaccine against malaria to receive a positive opinion from the European Medicines Agency will soon be tested in implementation trials in three African countries: Kenya, Malawi and Ghana.

Read the full article here

More News

EFIS Travel Grants for ALACI 2024

June 19, 2024European Federation of Immunological Societies (EFIS)

Travel4Expertise – The Grant for Caregivers

May 17, 2024Gender Equity Committee (GEC)

HOST AN IN-PERSON
IUIS IMMUNOLOGY
COURSE IN 2025

May 8, 2024Education Committee (EDU)

Michelson Prizes: Next Generation Grant

April 30, 2024Early Career Committee (ECC)

IUIS Junior Community: Pushing the Frontiers of Immunology

April 19, 2024Early Career Committee (ECC)

2024 Day of Immunology Webinar registration is live!

March 15, 2024

Call for Applications to join the IUIS Gender Equity Committee

March 1, 2024Gender Equity Committee (GEC)

IUIS/AAI AWARDS: SUMMER COURSES in IMMUNOLOGY

February 8, 2024American Association of Immunologists (AAI), Gender Equity Committee (GEC) and 1 more

Calling for Nominations to the EDU Committee & its online subcommittee

November 7, 2023Education Committee (EDU)